The aim of the study was to review the current literature on the role of vitamin D in dentistry. The term vitamin D is defined as a group of compounds which are cholesterol derivatives with a similar chemical structure. It is produced in the human body and passes through many stages of synthesis. Vitamin D affects our body through the immune, muscular, nervous, and cardiovascular systems. It is also relevant in dentistry and in the carbohydrate metabolism. Nowadays, vitamin D deficiency levels are high in both the Polish and the world population as a whole. This is due to many factors: latitude, diseases and lifestyle. The data shows that over 90% of people of color (black, Latino, Asian, etc.) and nearly 3/4 of whites living in the United States suffer from a shortage of 25-hydroxycholecalciferol (25(OH) vitamin D). Meanwhile, studies performed in Poland report that a concentration of vitamin D <20 ng/mL (50 nmol/mL) occurs in 70% of the population. Preliminary reports suggest that vitamin D, through the maintenance of normal bone metabolism, as well as its antibacterial and anti-inflammatory activity, modulates periodontal disease. A normal level of vitamin D is important in the treatment of periodontitis. More and more studies are focusing on the problem of vitamin D deficiency and its role in the human body. It is very important to maintain normal levels of vitamin D in the blood and supplement it in the case of shortfalls. 
Introduction
The term vitamin D refers to a group of chemical compounds that are cholesterol derivatives. Their similar chemical construction includes rings A, B, C, and D, and a side chain. Due to the B ring opening, vitamin D is classified as belonging to the secosteroid compound group. Vitamin D occurs in 2 basic forms: cholecalciferol (vitamin D 3 ) and ergocalciferol (vitamin D 2 ). They differ in terms of their side chain structure and their occurrence -cholecalciferol is present in animal organisms, while ergocalciferol is found in plants and fungi.
The 
Vitamin D metabolism
The synthesis of biologically active molecules in the human body involves a number of stages. The reaction precursor is a cholesterol derivative -7-dehydrocholesterol. It is present in the plasma membrane of keratinocytes, in the basal and spinous layer (called the Malpighian layer; at a volume of 0.4 mg/cm 2 ) and in dermis fibroblasts, where under UV radiation (wavelengths of 290-315 nm), in a photochemical reaction, it is transformed over the course of 30 min into lumisterol or tachysterol.
Next, at a high temperature (a skin temperature of 25°C) and with the participation of a reductase enzyme, isomerization to cholecalciferol (calciol) begins. This is a stable compound, which is released into the extracellular matrix and then into the blood, where it binds to a specific globulin, which in turn binds vitamin D (vitamin D binding protein -DBP) and is transported to the liver. The 1 st hydroxylation process takes place in the presence of vitamin D 25-hydroxylase, which is dependent on P-450 cytochrome (CYP27A1). This leads to the creation of 25-hydroxycholecalciferol (25(OH) vitamin D, calcidiol). The biological activity of this compound is low and its surplus is stored in adipocytes.
The next stage that takes place in renal proximal tubules is 1α-hydroxylation of the calcidiol A ring, involving 1α-hydroxylase (CYP27B1). During this reaction, 1,25-dihydroxy-cholecalciferol (1,25(OH) 2 D3, calcitriol) is formed. It is described as a vitamin hormone, the activity of which is 1,000 times higher as compared to calcidiol, but its half-life is shorter, i.e., 4-6 h. Calcitriol regulates numerous processes in the body, e.g., renal excretion of calcium (Ca) and phosphate with the urine, and increases osteolytic activity of parathyroid hormone (parathormone, PTH). Moreover, it lowers the immunity of the bone tissue to PTH activity, sensitizes parathyroid cells to calcemia transitions, increases the number of Ca ion receptors, simplifies the flow of ions to parathyroid cells and therefore reduces the secretion of PTH, and takes part in Ca absorption from the digestive tract. Calcitriol plays an essential role in the mineralization of bones, regulates the immunological processes, has an impact on cell proliferation and differentiation, and also may increase myopathy and cardiomyopathy. 1 This stage in the synthesis process is activated by the accumulation of 1,25(OH) 2 D3 metabolite, hypocalcemia, hypophosphatemia, and an elevated concentration of PTH. Tyrosine, estrogens, androgens, insulin, prolactin, cortisol, and somatotropin also exert a positive impact on hydroxylation. 2 What is essential is that the 1α-hydroxylation process also occurs in other human cells, such as macrophages, keratinocytes, placenta, parathyroid and prostate cells, osteoblasts, immune system cells, pancreatic islets, smooth muscle tissue cells, and tumor cells. Locally synthesized vitamin D impacts physiological processes at synthesis points [3] [4] [5] by auto-and paracrine regulation. Vitamin D is also delivered to the body through a proper diet, although it only accounts for approx. 10% of the total concentration. Products rich in cholecalciferol include fish and cod-liver oil. Milk, eggs and cheese also contain cholecalciferol, but in lower amounts. Legume plants are rich in ergocalciferol.
The vitamin D receptor
Vitamin D affects the human body and its particular systems by binding with a specific calcitriol receptor called the vitamin D receptor (VDR). It is present in over 30 tissues and organs, including the bones, kidneys, intestine, heart, brain, skin, pancreas, blood vessels, hypophysis, adrenal glands, and striated and smooth muscle tissue, as well as in T and B lymphocytes, neutrophils and macrophages. This suggests that the functioning of vitamin D is pleiotropic (heliotropic) in character.
The vitamin D receptor belongs to the steroid hormone receptor superfamily. It is a specific nuclear receptor. Its molecular mass equals approx. 55 kDa, it consists of 427 amino acid residues and is encoded by the VDR gene. The gene which encodes the vitamin D receptor protein is located in the 2 nd arm of chromosome 12. It consists of 9 exons, which are transcriptional DNA sequences, and of intertwined mRNA particles, which create transcriptional RNA. This gene is highly volatile due to mutations in the non-coded region.
Several polymorphisms of the VDR gene are known. The most common are single nucleotide polymorphisms (SNPs) -FokI (C/T), BsmI (A/G), ApaI (A/C), TaqI (T/C), and Cdx2 (A/G). Their names come from the restriction site that was originally used to identify them. FokI (rs2228570, C/T) polymorphism is located in the 2 nd start codon (ATG) in exon 2. When the C (mutant) allele is present, an alternative start site is used, leading to the expression of a shorter VDR protein (424 aa), which demonstrates a greater transcriptional activity as a consequence of enhanced binding to transcription factor II B. The T (wild-type) allele leads to the expression of a longer VDR protein (427 aa).
6 BsmI (rs1544410), ApaI (rs7975232) and TaqI (rs731236) polymorphisms are located in the 3' untranslated region (UTR), and are all involved in regulating the stability of VDR mRNA. 7, 8 The calcitriol receptor comprises 2 important fragments. The larger fragment (ligand-binding domain; the activation function for regulating gene transcription through calcitriol) is responsible for binding with the active form of vitamin D, and the smaller fragment (DNAbinding domain; dimerization) is responsible for binding with the regulatory DNA sequences of protein coding genes, whose expression is modulated by vitamin D (i.e., osteocalcin, osteopontin, collagen, alkaline phosphatase, hydroxycholecalciferol, parathyroid hormone). 1, 9 There are over 50 genes involved in Ca/P homeostasis. They are responsible for cell proliferation and differentiation, and immune response.
The ligand-binding domain with calcitriol is characterized by a low yield but a high affinity. It is composed of 80 amino acids, where 20 combine to build 2 tin fingers, with 3 amino acids that are crucial at the base. Here, after calcitriol binding, serine residue phosphorylation begins in positions 51, 119 and 125. Due to this process, it is possible to recognize the characteristic sequence in the promoter region of the target gene -vitamin D-responsive element (VDRE). The modification of the binding domain of the ligand may result in a lack of or poor responses to vitamin D. 10, 11 The dimerization domain is located near the ligandbinding domain. It consists of a sequence of 7 hydrophobic amino acids, repeated 9 times. The binding of calcitriol induces a conformational change in the dimerization domain, which enables the binding to the retinoic acid receptor-retinoid X receptor (RXR) so as to form a heterodimer, and then the specific binding of the heterodimer to the regulatory sequences of DNA. 14 This deficiency is determined by a concentration of <30 ng/mL (75 nmol/ mL) in the blood serum. Adams and Hewison have published data which shows that over 90% of people of color (black, Latino and Asians) and nearly 3/4 of whites living in the United States suffer from a shortage of 25(OH) vitamin D. 15, 16 Meanwhile, studies performed in Poland report that a concentration of vitamin D <20 ng/mL (50 nmol/mL) occurs in 70% of the population. 17, 18 The main reasons for vitamin D deficiency are as follows: latitude (though also in countries with high insolation, such as India, vitamin D deficiency is becoming a growing problem), usage of UVB filters, lifestyle, vocation, melanin deficiencies in the skin, aging, air pollution, inadequate dietary intake and supplements. 19, 20 An inadequate concentration of vitamin D is also accompanied by other diseases: cirrhosis of the liver, kidney dysfunctions, malabsorption, and obesity. It can also be a consequence of drug treatment (long-term intake of glucocorticoids, anti-epileptic drugs or ketoconazole).
Vitamin D concentration in the serum is determined using immunochemical methods, or a more accurate and sensitive technique of liquid chromatography-tandem mass spectrometry (LC-MS/MS). This method consists in isolating a single ion from a substance present in the sample by calculating the fraction mass-to-charge of ions. In tests determining vitamin D levels, liquid chromatography (LC) is used, which in the initial phase can precisely extract particles for further spectrometer analysis.
25-hydroxyvitamin D (25(OH)D)
, due to its stability in the serum and the fact that the speed of its synthesis is dependent on the supply of ingested vitamin D from diet, drugs or supplements, it is regarded as a marker and the best indicator of vitamin D concentration in the body. It is worth performing laboratory tests to measure both subunit 25(OH)D2 and 25(OH)D3. The sum of their total concentrations represents the total vitamin D concentration in the serum. 21 Depending on the level of vitamin D deficiency and the age of the patient, various supplementation doses have been proposed. Table 1 shows the dosing regimen for adults aged >18 years according to the concentration of vitamin D. The recommended total dose of vitamin D in therapy can also be calculated using the Groningen formula 22 :
where 1 ng/mL = 2.5 nmol/mL.
It is essential that supplementation in the form of tablets is applied after a meal, due to better absorption and the presence of agents containing vitamin K 2 MK-7, which affects bone metabolism through activating and enhancing matrix Gla-protein (MGP). The supply may be carried out using ergocalciferol (vitamin D 2 ), cholecalciferol (vitamin D 3 ) or calcifediol (25(OH)D3). The latter is used in the treatment of liver diseases, and complications arising from glucocorticosteroid treatment and antiepileptic drugs. The administration of calcitriol and its derivatives has no effect on improving the performance of vitamin D 3 , defined as an increase in the concentration of 25(OH) D3 in the serum, and is treated as hormonal treatment.
Vitamin D in medicine
Due to the discovery of the presence of VDR in many tissues, it has been proven that the effects of its action are wide and regard many systems. Its influence, beyond the skeletal system, has been shown for example in the immune, muscle, neural, and circulatory systems, as well as in dermal diseases, rheumatic diseases, mental disorders, and in anticancer activities. Thanks to such multidirectional effects, vitamin D has become known as the vitamin of life.
Vitamin D in dentistry
Vitamin D plays an important role in the stomatognathic system, where its influence in preventing caries has been demonstrated. An analysis by Hujoel points to vitamin D as one of the promising factors preventing caries. 23 The same study showed that vitamin D supplementation was correlated with a 47% lower risk of caries. This effect was achieved through better tooth development, changes in the amount or biochemical composition of saliva, modulated caries activity due to immunological factors, [24] [25] [26] and stimulating the production of antimicrobial peptides, such as defensins and cathelicidin. 27 It is also known that vitamin D can modulate Behçet's disease, aphthous stomatitis and Sjögren's syndrome. 27 There are reports on the existence of a correlation between the level of vitamin D and the activity of various diseases, including acromegaly. 28, 29 Halupczok-Żyła et al. found vitamin D deficiency in all patients with the active form of acromegaly. 29 There was also a statistically significant difference in the level of vitamin D between the control group and active acromegaly patients. 29 Another study suggests that VDR FokI genotypes might affect the development of acromegaly and VDR polymorphisms, and may play a role in the course of acromegaly as a consequence of altering the hormonal status. 30 Vitamin D is also capable of modifying the course of periodontal disease. There are 3 basic mechanisms responsible for this: the maintenance of normal bone metabolism, antibacterial activity and anti-inflammatory activity. The impact of vitamin D and its active metabolites on the skeletal system occurs through the regulation of the Ca metabolism. The level of 25(OH) vitamin D in the serum is positively correlated with the degree of bone mineralization, and negatively with the concentration of PTH.
Chronic vitamin D deficiency results in abnormal Ca absorption in the small intestine, which in turn reduces its blood concentration. In consequence, parathyroid glands increase the production of PTH (thereby developing tertiary hyperparathyroidism), which, by affecting the bone, increases the release of Ca into the blood to compensate for the deficiency in the serum.
This process is driven by the activation of osteoclasts, which results in the destruction of bone tissue, leading in turn to a reduction in bone calcification, rickets, osteomalacia, and osteoporosis. The role of vitamin D in the bone mineralization process can be proven by the fact that the condition of bone tissue deteriorates during the winter/spring, when the synthesis of vitamin D through the action of sunlight is considerably reduced. 31 Vitamin D can reduce bone resorption by increasing intestinal absorption of Ca and its reabsorption in the distal renal tubules. However, it also accelerates the secretion of calcitonin and decreases parathyroid cell proliferation, which in turn inhibits the synthesis and activity of PTH. It also aids bone repair processes and bone matrix synthesis, reduces the perforation of trabeculae and increases the activity of bone growth factors.
The antibacterial activity of vitamin D is based primarily on the induction of secretion of beta-defensins and cathelicidin LL-37 (showing the chemotactic activity of neutrophils, monocytes and T lymphocytes), for example by human gingival epithelial cells (GEC), and thereby modulating the innate immune response. Another important issue is the fact that calcitriol affects the regulation of triggering receptor expressed on myeloid cells (TREM-1), which is a key amplifier initiating the immune responses of macrophages, which in turn leads to increased production of inflammatory response genes. This information suggests that vitamin D may be used to treat and prevent infectious diseases of the mouth. In light of all the reports mentioned above, researchers have begun to closely observe and study any possible correlation between the effects of vitamin D and the course of periodontal diseases. [33] [34] [35] [36] Vitamin D has a multi-level role in maintaining periodontal health, namely, in reducing alveolar bone loss, gingival inflammation and/or attachment loss. Dietrich et al. used the Third National Health and Nutrition Examination Survey (NHANES III) to show that a lower level of vitamin D is associated with greater loss of attachment. 36 Another interesting conclusion of this analysis was that people with high vitamin D levels showed 20% less bleeding on probing. It is worth noting that these results were independent of other factors, such as diabetes or smoking. Such effects are evidence of the anti-inflammatory activity of vitamin D. 37 Studies conducted by Perayil et al. demonstrated the inhibiting effect of vitamin D and Ca supplementation on periodontitis. 38 They observed a statistically significant decrease in gingival index (GI) and simplified oral hygiene index (OHI-S) among patients taking an additional 250 IU of vitamin D and 500 mg of Ca, compared to those patients whose treatment consisted solely in scaling, root planing and curettage. Moreover, the bone density of respondents from the experimental group significantly increased. Hiremath et al. showed that vitamin D was a safe and effective anti-inflammatory agent when used in the treatment of gingivitis. 39 This characteristic leads to a reduced risk of tooth loss. 40 According to Mangano et al., the risk of early implant loss is more than 4 times higher in people with deficient vitamin D (<10 ng/mL) than in patients with normal serum vitamin D levels. 41 
Conclusions
The above discussion points out the importance of maintaining normal levels of vitamin D in the blood. Scientists have again started to examine the effect of vitamin D on many processes. They also highlight the fact that there is a general deficiency of vitamin D and the need for appropriate supplementation.
An analysis of the available publications clearly shows that more attention should be paid to the role of vitamin D deficiency in the etiology and treatment of periodontal diseases, as well as to vitamin D supplementation as an aid in treating periodontitis and gingivitis. In addition, it is worth focusing on possible vitamin D deficiency as a factor that increases the risk of bone implant loss.
